Polymorphisms in NFKB1 and TLR4 and interaction with dietary and life style factors in relation to colorectal cancer in a Danish prospective case-cohort study

PLoS ONE

Volumn 10, Issue 2, 2015, Pages

  Kopp, Tine Iskov ^a   Andersen, Vibeke ^b,c,d   Tjonneland, Anne ^e   Vogel, Ulla ^f  

^a TECHNICAL UNIVERSITY OF DENMARK   (Denmark)

^b Hospital of Southern Jutland   (Denmark)

^c UNIVERSITY OF SOUTHERN DENMARK   (Denmark)

^d VIBORG HOSPITAL   (Denmark)

^e DANISH CANCER SOCIETY RESEARCH CENTER   (Denmark)

^f NATIONAL RESEARCH CENTRE FOR THE WORKING ENVIRONMENT   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

NUCLEAR FACTOR KAPPA B1; TOLL LIKE RECEPTOR 4; TRANSCRIPTION FACTOR; UNCLASSIFIED DRUG; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; NFKB1 PROTEIN, HUMAN;

ADULT; ARTICLE; CANCER RISK; CARCINOGENESIS; COHORT ANALYSIS; COLORECTAL CANCER; CONTROLLED STUDY; DANISH CITIZEN; DIETARY INTAKE; FEMALE; GENE DELETION; GENE INSERTION; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENETIC VARIABILITY; GENOTYPE ENVIRONMENT INTERACTION; HOMOZYGOTE; HUMAN; LIFESTYLE; MAJOR CLINICAL STUDY; MALE; NFKB1 GENE; PROSPECTIVE STUDY; SINGLE NUCLEOTIDE POLYMORPHISM; TLR4 GENE; ALLELE; CASE CONTROL STUDY; COLORECTAL TUMOR; DENMARK; DIET; GENETIC PREDISPOSITION; GENETICS; GENOTYPE; MIDDLE AGED; PATHOLOGY;

ALLELES; CASE-CONTROL STUDIES; COLORECTAL NEOPLASMS; DENMARK; DIET; FEMALE; GENE-ENVIRONMENT INTERACTION; GENETIC ASSOCIATION STUDIES; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; LIFE STYLE; MALE; MIDDLE AGED; NF-KAPPA B P50 SUBUNIT; POLYMORPHISM, SINGLE NUCLEOTIDE; PROSPECTIVE STUDIES; TOLL-LIKE RECEPTOR 4;

EID: 84923797210     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0116394     Document Type: Article

References (73)

1. Ferlay J, Soerjomataram I, Ervik M, Dikshit R, Eser S, et al. (2014) GLOBOCAN 2012 v1.0, cancer incidence and mortality worldwide: IARC CancerBase no. 11 [internet].
2. Lichtenstein P, Holm NV, Verkasalo PK, Iliadou A, Kaprio J, et al. (2000) Environmental and heritable factors in the causation of cancer - analyses of cohorts of twins from sweden, denmark, and finland. N Engl J Med 343: 78-85. PMID: 10891514
3. Durko L, Malecka-Panas E (2014) Lifestyle modifications and colorectal cancer. Curr Colorectal Cancer Rep 10: 45-54. PMID: 24659930
4. Cogliano VJ, Baan R, Straif K, Grosse Y, Lauby-Secretan B, et al. (2011) Preventable exposures associated with human cancers. J Natl Cancer Inst 103: 1827-1839. doi: 10.1093/jnci/djr483 PMID: 22158127
5. Huxley RR, Ansary-Moghaddam A, Clifton P, Czernichow S, Parr CL, et al. (2009) The impact of dietary and lifestyle risk factors on risk of colorectal cancer: A quantitative overview of the epidemiological evidence. Int J Cancer 125: 171-180. doi: 10.1002/ijc.24343 PMID: 19350627
6. Santarelli RL, Pierre F, Corpet DE (2008) Processed meat and colorectal cancer: A review of epidemiologic and experimental evidence. Nutr Cancer 60: 131-144. doi: 10.1080/01635580701684872 PMID: 18444144
7. Le Leu RK, Young GP (2007) Fermentation of starch and protein in the colon: Implications for genomic instability. Cancer Biol Ther 6: 259-260. PMID: 17426435
8. Cummings JH, Hill MJ, Bone ES, Branch WJ, Jenkins DJ (1979) The effect of meat protein and dietary fiber on colonic function and metabolism. II. bacterial metabolites in feces and urine. Am J Clin Nutr 32: 2094-2101. PMID: 484528
9. Geypens B, Claus D, Evenepoel P, Hiele M, Maes B, et al. (1997) Influence of dietary protein supplements on the formation of bacterial metabolites in the colon. Gut 41: 70-76. PMID: 9274475
10. Le Leu RK, Young GP, Hu Y, Winter J, Conlon MA (2013) Dietary red meat aggravates dextran sulfate sodium-induced colitis in mice whereas resistant starch attenuates inflammation. Dig Dis Sci 58: 3475-3482. doi: 10.1007/s10620-013-2844-1 PMID: 23990000
11. Bingham SA, Day NE, Luben R, Ferrari P, Slimani N, et al. (2003) Dietary fibre in food and protection against colorectal cancer in the european prospective investigation into cancer and nutrition (EPIC): An observational study. Lancet 361: 1496-1501. PMID: 12737858
12. Murphy N, Norat T, Ferrari P, Jenab M, Bueno-de-Mesquita B, et al. (2012) Dietary fibre intake and risks of cancers of the colon and rectum in the european prospective investigation into cancer and nutrition (EPIC). PLoS One 7: e39361. doi: 10.1371/journal.pone.0039361 PMID: 22761771
13. Bingham SA (1990) Mechanisms and experimental and epidemiological evidence relating dietary fibre (non-starch polysaccharides) and starch to protection against large bowel cancer. Proc Nutr Soc 49: 153-171. PMID: 2172992
14. De Preter V, Rutgeerts P, Schuit F, Verbeke K, Arijs I (2013) Impaired expression of genes involved in the butyrate oxidation pathway in crohn's disease patients. Inflamm Bowel Dis 19: E43-4. doi: 10.1002/ibd.22970 PMID: 22508661
15. Young GP, Hu Y, Le Leu RK, Nyskohus L (2005) Dietary fibre and colorectal cancer: A model for environment - gene interactions. Mol Nutr Food Res 49: 571-584. PMID: 15864783
16. Whitehead RH, Young GP, Bhathal PS (1986) Effects of short chain fatty acids on a new human colon carcinoma cell line (LIM1215). Gut 27: 1457-1463. PMID: 3804021
17. Heerdt BG, Houston MA, Augenlicht LH (1997) Short-chain fatty acid-initiated cell cycle arrest and apoptosis of colonic epithelial cells is linked to mitochondrial function. Cell Growth Differ 8: 523-532. PMID: 9149903
18. Segain JP, Raingeard de la Bletiere D, Bourreille A, Leray V, Gervois N, et al. (2000) Butyrate inhibits inflammatory responses through NFkappaB inhibition: Implications for crohn's disease. Gut 47: 397-403. PMID: 10940278
19. Abreu MT (2010) Toll-like receptor signalling in the intestinal epithelium: How bacterial recognition shapes intestinal function. Nat Rev Immunol 10: 131-144. doi: 10.1038/nri2707 PMID: 20098461
20. Slattery ML, Herrick JS, Bondurant KL, Wolff RK (2012) Toll-like receptor genes and their association with colon and rectal cancer development and prognosis. Int J Cancer 130: 2974-2980. doi: 10.1002/ijc.26314 PMID: 21792899
21. Fukata M, Chen A, Klepper A, Krishnareddy S, Vamadevan AS, et al. (2006) Cox-2 is regulated by tolllike receptor-4 (TLR4) signaling: Role in proliferation and apoptosis in the intestine. Gastroenterology 131: 862-877. PMID: 16952555
22. Hornef MW, Normark BH, Vandewalle A, Normark S (2003) Intracellular recognition of lipopolysaccharide by toll-like receptor 4 in intestinal epithelial cells. J Exp Med 198: 1225-1235. PMID: 14568981
23. Garlanda C, Riva F, Veliz T, Polentarutti N, Pasqualini F, et al. (2007) Increased susceptibility to colitis-associated cancer of mice lacking TIR8, an inhibitory member of the interleukin-1 receptor family. Cancer Res 67: 6017-6021. PMID: 17616656
24. Xiao H, Gulen MF, Qin J, Yao J, Bulek K, et al. (2007) The toll-interleukin-1 receptor member SIGIRR regulates colonic epithelial homeostasis, inflammation, and tumorigenesis. Immunity 26: 461-475. PMID: 17398123
25. Fukata M, Hernandez Y, Conduah D, Cohen J, Chen A, et al. (2009) Innate immune signaling by toll-like receptor-4 (TLR4) shapes the inflammatory microenvironment in colitis-associated tumors. Inflamm Bowel Dis 15: 997-1006. doi: 10.1002/ibd.20880 PMID: 19229991
26. Fukata M, Abreu MT (2007) TLR4 signalling in the intestine in health and disease. Biochem Soc Trans 35: 1473-1478. PMID: 18031248
27. Andersen V, Holst R, Kopp TI, Tjonneland A, Vogel U (2013) Interactions between diet, lifestyle and IL10, IL1B, and PTGS2/COX-2 gene polymorphisms in relation to risk of colorectal cancer in a prospective danish case-cohort study. PLoS One 8: e78366. doi: 10.1371/journal.pone.0078366 PMID: 24194923
28. Andersen V, Holst R, Vogel U (2013) Systematic review: Diet-gene interactions and the risk of colorectal cancer. Aliment Pharmacol Ther 37: 383-391. doi: 10.1111/apt.12180 PMID: 23216531
29. Bank S, Skytt Andersen P, Burisch J, Pedersen N, Roug S, et al. (2014) Polymorphisms in the inflammatory pathway genes TLR2, TLR4, TLR9, LY96, NFKBIA, NFKB1, TNFA, TNFRSF1A, IL6R, IL10, IL23R, PTPN22, and PPARG are associated with susceptibility of inflammatory bowel disease in a danish cohort. PLoS One 9: e98815. doi: 10.1371/journal.pone.0098815 PMID: 24971461
30. Andersen V, Christensen J, Overvad K, Tjonneland A, Vogel U (2010) Polymorphisms in NFkB, PXR, LXR and risk of colorectal cancer in a prospective study of danes. BMC Cancer 10: 484-2407-10-484.
31. Mohd Suzairi MS, Tan SC, Ahmad Aizat AA, Mohd Aminudin M, Siti Nurfatimah MS, et al. (2013) The functional-94 insertion/deletion ATTG polymorphism in the promoter region of NFKB1 gene increases the risk of sporadic colorectal cancer. Cancer Epidemiol 37: 634-638. doi: 10.1016/j.canep.2013.05.007 PMID: 23806437
32. Lewander A, Butchi AK, Gao J, He LJ, Lindblom A, et al. (2007) Polymorphism in the promoter region of the NFKB1 gene increases the risk of sporadic colorectal cancer in swedish but not in chinese populations. Scand J Gastroenterol 42: 1332-1338. PMID: 17852842
33. Eyking A, Ey B, Runzi M, Roig AI, Reis H, et al. (2011) Toll-like receptor 4 variant D299G induces features of neoplastic progression in caco-2 intestinal cells and is associated with advanced human colon cancer. Gastroenterology 141: 2154-2165. doi: 10.1053/j.gastro.2011.08.043 PMID: 21920464
34. Browning BL, Huebner C, Petermann I, Gearry RB, Barclay ML, et al. (2007) Has toll-like receptor 4 been prematurely dismissed as an inflammatory bowel disease gene? association study combined with meta-analysis shows strong evidence for association. Am J Gastroenterol 102: 2504-2512. PMID: 17850411
35. Brand S, Staudinger T, Schnitzler F, Pfennig S, Hofbauer K, et al. (2005) The role of toll-like receptor 4 Asp299Gly and Thr399Ile polymorphisms and CARD15/NOD2 mutations in the susceptibility and phenotype of crohn's disease. Inflamm Bowel Dis 11: 645-652.
36. Franchimont D, Vermeire S, El Housni H, Pierik M, Van Steen K, et al. (2004) Deficient host-bacteria interactions in inflammatory bowel disease? the toll-like receptor (TLR)-4 Asp299gly polymorphism is associated with crohn's disease and ulcerative colitis. Gut 53: 987-992. PMID: 15194649
37. De Jager PL, Franchimont D, Waliszewska A, Bitton A, Cohen A, et al. (2007) The role of the toll receptor pathway in susceptibility to inflammatory bowel diseases. Genes Immun 8: 387-397. PMID: 17538633
38. Kutikhin AG, Yuzhalin AE, Volkov AN, Zhivotovskiy AS, Brusina EB (2014) Correlation between genetic polymorphisms within IL-1B and TLR4 genes and cancer risk in a russian population: A case-control study. Tumour Biol.
39. Pimentel-Nunes P, Teixeira AL, Pereira C, Gomes M, Brandao C, et al. (2013) Functional polymorphisms of toll-like receptors 2 and 4 alter the risk for colorectal carcinoma in europeans. Dig Liver Dis 45: 63-69. doi: 10.1016/j.dld.2012.08.006 PMID: 22999059
40. Boraska Jelavic T, Barisic M, Drmic Hofman I, Boraska V, Vrdoljak E, et al. (2006) Microsatelite GT polymorphism in the toll-like receptor 2 is associated with colorectal cancer. Clin Genet 70: 156-160. PMID: 16879199
41. Omrane I, Baroudi O, Kourda N, Bignon YJ, Uhrhammer N, et al. (2014) Positive link between variant toll-like receptor 4 (Asp299Gly and Thr399Ile) and colorectal cancer patients with advanced stage and lymph node metastasis. Tumour Biol 35: 545-551. doi: 10.1007/s13277-013-1075-6 PMID: 23949880
42. Davoodi H, Seow HF (2011) Variant toll-like receptor4 (Asp299Gly and Thr399Ile alleles) and toll-like receptor2 (Arg753Gln and Arg677Trp alleles) in colorectal cancer. Iran J Allergy Asthma Immunol 10: 91-99. doi: 010.02/ijaai.9199 PMID: 21625017
43. Landi S, Gemignani F, Bottari F, Gioia-Patricola L, Guino E, et al. (2006) Polymorphisms within inflammatory genes and colorectal cancer. J Negat Results Biomed 5: 15. PMID: 17062130
44. Cuda C, Badawi A, Karmali M, El-Sohemy A (2011) Polymorphisms in toll-like receptor 4 are associated with factors of the metabolic syndrome and modify the association between dietary saturated fat and fasting high-density lipoprotein cholesterol. Metabolism 60: 1131-1135. doi: 10.1016/j.metabol.2010. 12.006 PMID: 21306745
45. Tjonneland A, Olsen A, Boll K, Stripp C, Christensen J, et al. (2007) Study design, exposure variables, and socioeconomic determinants of participation in diet, cancer and health: A population-based prospective cohort study of 57,053 men and women in denmark. Scand J Public Health 35: 432-441. PMID: 17786808
46. Barlow WE, Ichikawa L, Rosner D, Izumi S (1999) Analysis of case-cohort designs. J Clin Epidemiol 52: 1165-1172. PMID: 10580779
47. Andersen V, Christensen J, Ernst A, Jacobsen BA, Tjonneland A, et al. (2011) Polymorphisms in NFkappaB, PXR, LXR, PPARgamma and risk of inflammatory bowel disease. World J Gastroenterol 17: 197-206. doi: 10.3748/wjg.v17.i2.197 PMID: 21245992
48. Andersen V, Egeberg R, Tjonneland A, Vogel U (2012) Interaction between interleukin-10 (IL-10) polymorphisms and dietary fibre in relation to risk of colorectal cancer in a danish case-cohort study. BMC Cancer 12: 183-2407-12-183.
49. Tjonneland A, Overvad K, Haraldsdottir J, Bang S, Ewertz M, et al. (1991) Validation of a semiquantitative food frequency questionnaire developed in denmark. Int J Epidemiol 20: 906-912. PMID: 1800429
50. Miller SA, Dykes DD, Polesky HF (1988) A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res 16: 1215. PMID: 3344216
51. Barrett JC, Fry B, Maller J, Daly MJ. (2005) Haploview: Analysis and visualization of LD and haplotype maps. Bioinformatics 21: 263-265. PMID: 15297300
52. International HapMap Consortium (2003) The international HapMap project. Nature 426: 789-796. PMID: 14685227
53. Barlow WE (1994) Robust variance estimation for the case-cohort design. Biometrics 50: 1064-1072. PMID: 7786988
54. Andersen V, Ostergaard M, Christensen J, Overvad K, Tjonneland A, et al. (2009) Polymorphisms in the xenobiotic transporter multidrug resistance 1 (MDR1) and interaction with meat intake in relation to risk of colorectal cancer in a danish prospective case-cohort study. BMC Cancer 9: 407-2407-9-407.
55. Vogel U, Christensen J, Dybdahl M, Friis S, Hansen RD, et al. (2007) Prospective study of interaction between alcohol, NSAID use and polymorphisms in genes involved in the inflammatory response in relation to risk of colorectal cancer. Mutat Res 624: 88-100. PMID: 17544013
56. Andersen V, Christensen J, Overvad K, Tjonneland A, Vogel U (2011) Heme oxygenase-1 polymorphism is not associated with risk of colorectal cancer: A danish prospective study. Eur J Gastroenterol Hepatol 23: 282-285. doi: 10.1097/MEG.0b013e3283417f76 PMID: 21191307
57. Andersen V, Agerstjerne L, Jensen D, Ostergaard M, Saebo M, et al. (2009) The multidrug resistance 1 (MDR1) gene polymorphism G-rs3789243-A is not associated with disease susceptibility in norwegian patients with colorectal adenoma and colorectal cancer; a case control study. BMC Med Genet 10: 18-2350-10-18.
58. Andersen V, Egeberg R, Tjonneland A, Vogel U (2012) ABCC2 transporter gene polymorphisms, diet and risk of colorectal cancer: A danish prospective cohort study. Scand J Gastroenterol 47: 572-574. doi: 10.3109/00365521.2012.668933 PMID: 22428913
59. Hansen RD, Krath BN, Frederiksen K, Tjonneland A, Overvad K, et al. (2009) GPX1 pro(198)leu polymorphism, erythrocyte GPX activity, interaction with alcohol consumption and smoking, and risk of colorectal cancer. Mutat Res 664: 13-19. doi: 10.1016/j.mrfmmm.2009.01.009 PMID: 19428376
60. Hansen RD, Sorensen M, Tjonneland A, Overvad K, Wallin H, et al. (2008) A haplotype of polymorphisms in ASE-1, RAI and ERCC1 and the effects of tobacco smoking and alcohol consumption on risk of colorectal cancer: A danish prospective case-cohort study. BMC Cancer 8: 54-2407-8-54.
61. Hansen RD, Sorensen M, Tjonneland A, Overvad K, Wallin H, et al. (2007) XPA A23G, XPC Lys939Gln, XPD Lys751Gln and XPD Asp312Asn polymorphisms, interactions with smoking, alcohol and dietary factors, and risk of colorectal cancer. Mutat Res 619: 68-80. PMID: 17363013
62. Friis S, Poulsen AH, Sorensen HT, Tjonneland A, Overvad K, et al. (2009) Aspirin and other non-steroidal anti-inflammatory drugs and risk of colorectal cancer: A danish cohort study. Cancer Causes Control 20: 731-740. doi: 10.1007/s10552-008-9286-7 PMID: 19122977
63. Karban AS, Okazaki T, Panhuysen CI, Gallegos T, Potter JJ, et al. (2004) Functional annotation of a novel NFKB1 promoter polymorphism that increases risk for ulcerative colitis. Hum Mol Genet 13: 35-45. PMID: 14613970
64. Borm ME, van Bodegraven AA, Mulder CJ, Kraal G, Bouma G (2005) A NFKB1 promoter polymorphism is involved in susceptibility to ulcerative colitis. Int J Immunogenet 32: 401-405. PMID: 16313306
65. Vogel U, Jensen MK, Due KM, Rimm EB, Wallin H, et al. (2011) The NFKB1 ATTG ins/del polymorphism and risk of coronary heart disease in three independent populations. Atherosclerosis 219: 200-204. doi: 10.1016/j.atherosclerosis.2011.06.018 PMID: 21726863
66. Kopp TI, Friis S, Christensen J, Tjonneland A, Vogel U (2013) Polymorphisms in genes related to inflammation, NSAID use, and the risk of prostate cancer among danish men. Cancer Genet 206: 266-278. doi: 10.1016/j.cancergen.2013.06.001 PMID: 23880210
67. Pereira SG, Oakley F (2008) Nuclear factor-kappaB1: Regulation and function. Int J Biochem Cell Biol 40: 1425-1430. PMID: 17693123
68. Perkins ND (2007) Integrating cell-signalling pathways with NF-kappaB and IKK function. Nat Rev Mol Cell Biol 8: 49-62. PMID: 17183360
69. Cao S, Zhang X, Edwards JP, Mosser DM (2006) NF-kappaB1 (p50) homodimers differentially regulate pro- and anti-inflammatory cytokines in macrophages. J Biol Chem 281: 26041-26050. PMID: 16835236
70. Ghosh S, May MJ, Kopp EB (1998) NF-kappa B and rel proteins: Evolutionarily conserved mediators of immune responses. Annu Rev Immunol 16: 225-260. PMID: 9597130
71. Andersen V, Vogel U, Godiksen S, Frenzel FB, Saebo M, et al. (2013) Low ABCB1 gene expression is an early event in colorectal carcinogenesis. PLoS One 8: e72119. doi: 10.1371/journal.pone.0072119 PMID: 23977225
72. Gast A, Bermejo JL, Claus R, Brandt A, Weires M, et al. (2011) Association of inherited variation in tolllike receptor genes with malignant melanoma susceptibility and survival. PLoS One 6: e24370. doi: 10.1371/journal.pone.0024370 PMID: 21931695
73. Bank S, Andersen PS, Burisch J, Pedersen N, Roug S, et al. (2014) Associations between functional polymorphisms in the NFkappaB signaling pathway and response to anti-TNF treatment in danish patients with inflammatory bowel disease. Pharmacogenomics J.